skip to Main Content

Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma

14th September 2021 – At IRBM we are passionate about helping companies develop medicines in a wide range of diseases and our scientists support the fundamental understanding of disease mechanisms. Science is about collaboration, and publication is an integral part of the scientific process. So, we are delighted to have out latest scientific paper published, produced in collaboration with several institutions including the University of Milan, and Milan’s Istituto Nazionale di Genetica Molecolare (INGM).

WHYUS

We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.

NewsEvents

Targeting Of EIF6-driven Translation Induces A Metabolic Rewiring That Reduces NAFLD And The Consequent Evolution To Hepatocellular Carcinoma

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma

In The News
At IRBM we are passionate about helping companies develop medicines in a wide range of diseases and our scientists support the fundamental understanding of disease mechanisms. Science is about collaboration, and publication is an integral part of the scientific process.
read more

IRBM & collaborators publish on techniques for characterizing peptides in Type 2 diabetes and a peptide drug discovery program for Huntington’s disease

In The News, Scientific Contributions
Nowadays, there is a strong drive to explore new areas of chemical space in search of innovative ways to bind and modulate challenging biological targets. At IRBM our peptide chemistry team has extensive expertise in peptide and macrocyclic drug discovery in various therapeutic areas.

On July 7 University and Research Minister Gaetano Manfredi visited IRBM

Events
“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.

On June 18 Health Minister Roberto Speranza, together with Nicola Magrini Director General of AIFA, visited IRBM

Events
"Only a safe, effective vaccine can take us out of the emergency. "We are proud of our scientists and of the excellence of Italian research" said minister Speranza.

IRBMPHOTOS

IRBMVIDEOS

Back To Top